Agencies
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Agencies | Published : October 1, 2016 5:17 PM IST
Exercise may not reduce a woman's risk of developing multiple sclerosis (MS) -- a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged, finds a study. We wanted to find out if exercise lowered the risk of developing MS in women. Our study did not provide evidence to support it, said Kassandra Munger, Researcher at the Harvard T.H. Chan School of Public Health in Boston, in a study published in the journal Neurology.Researchers evaluated data on more than 193,000 women and followed for up to 20-years.The women completed regular questionnaires about their physical activity and also about their activity as teens and young adults. During the study, 341 women developed MS.Researchers calculated the total hours of physical activity per week, took into account the type of exercise for each woman and adjusted for age, ethnicity, smoking, supplemental vitamin D, place of residence at the age of 15 years and body mass index at age 18. Overall, there was no consistent association of exercise at any age and MS. Exercise has been shown to be beneficial to people with the disease, but it seems unlikely that exercise protects against the risk of developing MS, Munger added.MS treatment options include disease-modifying drugs
Overall, there was no consistent association of exercise at any age and MS. Exercise has been shown to be beneficial to people with the disease, but it seems unlikely that exercise protects against the risk of developing MS, Munger added.MS treatment options include disease-modifying drugsmethylprednisolone, interferons (Avonex, Betaseron), Copaxone and Rebif that provide symptom relief and slowdown the disease progressionto prevent relapses. Counselling, physical and occupational therapy help to cope with movement and behavioural symptoms. MS is not fatal but complications arising from a weak immune system, such as pneumonia, lower life expectancy by ten years in MS patients.Richard A. Rudick (US-based MS expert) during a Feb 2012 presentation, at The TS Srinivasan Institute, observed that MS prevalence in India is probably underestimated because of a lack of awareness amongst patients and neurologists. Dr. Rudick, also declared that MS treatment had progressed beyond the ABCR drugs (Avonex, Betaseron and Copaxone and Rebif) to personalised medicine such that several drug combinations could be used to possibly completely block multiple sclerosis disease (MS) activity. (Read:Suffering from multiple sclerosis? Follow a diet that resembles fasting!)
Source: IANS
Image: Shutterstock
Disclaimer: The content on TheHealthSite.com is only for informational purposes. It is not at all professional medical advice. Always consult your doctor or a healthcare specialist for any questions regarding your health or a medical condition.